Antibodies against FcRn and use thereof

Details for Australian Patent Application No. 2009238605 (hide)

Owner Dyax Corp. Biogen Idec Hemophilia Inc.

Inventors Ladner, Robert Charles; Wood, Clive; Liu, Liming; Dumont, Jennifer; Muruganandam, Arumugam; Bitonti, Alan J.; McDonnell, Kevin; Sato, Aaron; Stattel, James; Tenhoor, Christopher

Agent Pizzeys

Pub. Number AU-A-2009238605

PCT Pub. Number WO2009/131702

Priority 61/048,500 28.04.08 US; 61/048,152 25.04.08 US

Filing date 24 April 2009

Wipo publication date 29 October 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

9 December 2010 Alteration of Name

  The name of the applicant has been altered to Dyax Corp.; Biogen Idec Hemophilia Inc.

16 December 2010 PCT application entered the National Phase

  PCT publication WO2009/131702 Priority application(s): WO2009/131702

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009238607-Nanostructures suitable for sequestering cholesterol

2009238602-Dynamic distractor